Plunkett Research Online: Galapagos NV

GALAPAGOS NV (GLPGF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Galapagos NV is a clinical-stage biotechnology company. It specializes in the discovery and development of small molecule medicines with novel modes of action, addressing disease areas of high unmet medical need. Execution on its proprietary drug target discovery platform has delivered a pipeline .....



Galapagos NV
Ticker: GLPGF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 32 15342900
Fax: 32 15342901
Address: Generaal De Wittelaan L11 A3
Mechelen, 2800 Belgium

Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology Research Services
ContactsDescription
Bart FiliusCFO
Piet WigerinckChief Scientific Officer
See More
Galapagos NV is a clinical-stage biotechnology company. It specializes in the discovery and development of small molecule medicines with novel modes of action, addressing disease areas of high unmet medical need. Execution on its proprietary drug target discovery platform has delivered a pipeline .....See More See More

Auditor: Deloitte Bedrijfsrevisoren / Reviseurs d?Entreprises
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
filgotinib
GLPG1690
GLPG1972
Fidelta
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: